Losartan Potassium Price In China
- China: 75015 USD/MT
The price of losartan potassium in China reached 75,015 USD per metric ton during Q4 2023. This increase was driven by limited supplies and heightened consumer demand during the festive season. Additionally, rising crude oil prices, resulting from extended production cuts by OPEC+ countries and the Israel-Hamas conflict, led to higher business expenses and output costs, further contributing to the price rise.
The latest report by IMARC, titled " Losartan Potassium Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data," delivers a comprehensive analysis of losartan potassium prices on a global and regional scale, highlighting the pivotal factors contributing to price changes. This detailed examination includes spot price evaluations at key ports and an analysis of pricing structures, such as Ex Works, FOB, and CIF, across North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Losartan Potassium Prices December 2023:
- China: 75015 USD/MT
Report Offering:
- Monthly Updates - Annual Subscription
- Quarterly Updates - Annual Subscription
- Biannually Updates - Annual Subscription
The study delves into the factors affecting losartan potassium price variations, including alterations in the cost of raw materials, the balance of supply and demand, geopolitical influences, and sector-specific developments.
The report also incorporates the most recent updates from the market, equipping stakeholders with the latest information on market fluctuations, regulatory modifications, and technological progress. It serves as an exhaustive resource for stakeholders, enhancing strategic planning and forecast capabilities.
Request For a Sample Copy of the Report: https:/www.imarcgroup.com/losartan-potassium-pricing-report/requestsample
Losartan Potassium Price Trend- Q4 2023
The losartan potassium market is driven by several dynamic factors that reflect economic trends and sector-specific developments. In North America, particularly the United States, the market experienced fluctuations, influenced by individual confidence and macroeconomic conditions. Initially, there was a significant rise in losartan potassium prices, fueled by increased spending of people, attributed to lower inflation and more affordable gas prices, which catalyzed overall market demand. This was compounded by a stronger domestic currency, making imports more expensive and thus tightening the supply in the local market. As the quarter progressed, these factors continued to play a critical role, with added complexity from seasonal demand during the holiday season. However, a recovery in inflation towards the end of the quarter prompted a cautious approach from individuals, leading to a decrease in demand. The price and demand for losartan potassium in this region illustrated the impact of economic indicators, such as inflation rates, individual spending, and foreign exchange rates on pharmaceutical inputs, highlighting the sensitivity of the market to broader economic shifts.
Losartan Potassium Market Analysis
The global losartan potassium market size reached 23.8 Thousand Tonnes in 2023. By 2032, IMARC Group expects the market to reach 35.4 Thousand Tonnes, at a projected CAGR of 4.50% during 2023-2032. Moreover, in Europe, similar trends were observed where increased initial prices were supported by strong demand from the food and beverage (F&B) and healthcare sectors and lower market inventories. However, rising inflation and interest rate hikes by central banks, intended to restrain inflation and decrease sentiment of people, along with declined business sentiment and reduced factory output, led to a surplus of supply that pushed prices down. These economic interventions illustrated the complicated balance between policy measures and market response, which directly impacted drug pricing and availability.
Meanwhile, in the APAC region, particularly China, the situation was slightly different. The market faced a tight supply scenario and rising input costs due to increased crude oil prices and geopolitical tensions affecting trade routes. Initially, this led to a spike in prices. However, as key players and distributors anticipated a downturn, they reduced prices to clear out inventories before the year-end, reflecting a strategic response to anticipated shifts in market demand and supply conditions. This strategic inventory management, combined with fluctuating demand and external economic pressures, outlined how events and local strategies worldwide complementary influenced the pricing of essential medications like losartan potassium across different markets.
Browse Full Report: https://www.imarcgroup.com/losartan-potassium-pricing-report
Key Points Covered in the Losartan Potassium Pricing Report:
The report delivers the following key findings, alongside a comprehensive breakdown of prices by region:
- Losartan Potassium Prices
- Losartan Potassium Price Trend
- Losartan Potassium Demand & Supply
- Losartan Potassium Market Analysis
- Demand Supply Analysis by Type
- Demand Supply Analysis by Application
- Demand Supply Analysis of Raw Materials
- Losartan Potassium Price Analysis
- Losartan Potassium Industry Drivers, Restraints, and Opportunities
- Losartan Potassium News and Recent developments
- Global Event Analysis
- List of Key Players
Regional Price Analysis:
- Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand
- Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece
- North America: United States and Canada
- Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru
- Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco
Browse More Pricing Reports by IMARC Group:
Note: The current country list is selective, detailed insights into additional countries can be obtained for clients upon request.
About Us:
IMARC is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
